These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10755679)

  • 21. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.
    Cruz BF; de Resende CB; Abreu MN; Rocha FL; Teixeira AL; Keefe RS; Salgado JV
    Cogn Neuropsychiatry; 2013 May; 18(3):243-51. PubMed ID: 23145794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
    Bak N; Ebdrup BH; Oranje B; Fagerlund B; Jensen MH; Düring SW; Nielsen MØ; Glenthøj BY; Hansen LK
    Transl Psychiatry; 2017 Apr; 7(4):e1087. PubMed ID: 28398342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The PANSS (Positive And Negative Symptom) Scale].
    Guelfi JD
    Encephale; 1997 Apr; 23 Spec No 2():35-8. PubMed ID: 9273305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The self-assessment scale of cognitive complaints in schizophrenia: a validation study in Tunisian population.
    Johnson I; Kebir O; Ben Azouz O; Dellagi L; Rabah Y; Tabbane K
    BMC Psychiatry; 2009 Oct; 9():66. PubMed ID: 19814827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
    Cuesta MJ; Peralta V
    Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the factor structure of symptoms in patients with schizophrenia.
    Kim JH; Kim SY; Lee J; Oh KJ; Kim YB; Cho ZH
    Psychiatry Res; 2012 May; 197(3):285-9. PubMed ID: 22364933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale.
    Eisenberg DP; Aniskin DB; White L; Stein JA; Harvey PD; Galynker II
    Psychopathology; 2009; 42(4):242-8. PubMed ID: 19451757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.
    Peralta V; Cuesta MJ
    Psychiatry Res; 1994 Jul; 53(1):31-40. PubMed ID: 7991730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptom structure and severity: a comparison of responses to the positive and negative syndrome scale (PANSS) between patients with PTSD or schizophrenia.
    Stefanovics EA; Krystal JH; Rosenheck RA
    Compr Psychiatry; 2014 May; 55(4):887-95. PubMed ID: 24602497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study.
    Harvey PD; Lombardi J; Leibman M; White L; Parrella M; Powchik P; Davidson M
    Schizophr Res; 1996 Dec; 22(3):223-31. PubMed ID: 9000319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-factor model of schizophrenia. Initial validation.
    Lindenmayer JP; Bernstein-Hyman R; Grochowski S
    J Nerv Ment Dis; 1994 Nov; 182(11):631-8. PubMed ID: 7964671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The five symptom dimensions and depression in schizophrenia.
    Lee KH; Harris AW; Loughland CM; Williams LM
    Psychopathology; 2003; 36(5):226-33. PubMed ID: 14571051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical dimensions of auditory hallucinations in schizophrenic disorders.
    Oulis P; Gournellis R; Konstantakopoulos G; Matsoukas T; Michalopoulou PG; Soldatos C; Lykouras L
    Compr Psychiatry; 2007; 48(4):337-42. PubMed ID: 17560954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia.
    Higashima M; Urata K; Kawasaki Y; Maeda Y; Sakai N; Mizukoshi C; Nagasawa T; Kamiya T; Yamaguchi N; Koshino Y
    Biol Psychiatry; 1998 Jul; 44(2):115-20. PubMed ID: 9646893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clock Drawing Test in patients with schizophrenia.
    Bozikas VP; Kosmidis MH; Gamvrula K; Hatzigeorgiadou M; Kourtis A; Karavatos A
    Psychiatry Res; 2004 Jan; 121(3):229-38. PubMed ID: 14675742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing positive and negative symptoms in children and adolescents.
    Fields JH; Grochowski S; Lindenmayer JP; Kay SR; Grosz D; Hyman RB; Alexander G
    Am J Psychiatry; 1994 Feb; 151(2):249-53. PubMed ID: 8296898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale.
    Bell MD; Lysaker PH; Beam-Goulet JL; Milstein RM; Lindenmayer JP
    Psychiatry Res; 1994 Jun; 52(3):295-303. PubMed ID: 7991723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.